Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Parissis

Showing results (231-240 of 238) with videos related to

Pageof 24
Sort By:
You have reached the last page of results.This site can display upto 238 results.
International Journal of Cardiology|October 17, 2019
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusDimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Journal of Heart Failure|May 4, 2025
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios Farmakis, et al.
European Heart Journal|April 9, 2019
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Javed Butler, Francois M Abboud, et al.
Cardiac Failure Review|July 28, 2020
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
European Journal of Heart Failure|June 13, 2023
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of CardiologyOvidiu Chioncel, Marianna Adamo, Maria Nikolaou, et al.
Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
Pageof 24

Showing results (231-240 of 238) with videos related to

Sort By:
Pageof 24
You have reached the last page of results.This site can display upto 238 results.
International Journal of Cardiology|October 17, 2019
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusDimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, et al.
European Journal of Heart Failure|May 30, 2020
Epidemiology, pathophysiology and contemporary management of cardiogenic shock - a position statement from the Heart Failure Association of the European Society of CardiologyOvidiu Chioncel, John Parissis, Alexandre Mebazaa, et al.
European Journal of Heart Failure|April 30, 2020
Acute coronary syndromes and acute heart failure: a diagnostic dilemma and high-risk combination. A statement from the Acute Heart Failure Committee of the Heart Failure Association of the European Society of CardiologyVeli-Pekka Harjola, John Parissis, Johann Bauersachs, et al.
European Journal of Heart Failure|May 4, 2025
Pathophysiology and clinical use of agents with vasodilator properties in acute heart failure. A scientific statement of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)Ovidiu Chioncel, Alexandre Mebazaa, Dimitrios Farmakis, et al.
European Heart Journal|April 9, 2019
The continuous heart failure spectrum: moving beyond an ejection fraction classificationFilippos Triposkiadis, Javed Butler, Francois M Abboud, et al.
Cardiac Failure Review|July 28, 2020
Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
European Journal of Heart Failure|June 13, 2023
Acute heart failure and valvular heart disease: A scientific statement of the Heart Failure Association, the Association for Acute CardioVascular Care and the European Association of Percutaneous Cardiovascular Interventions of the European Society of CardiologyOvidiu Chioncel, Marianna Adamo, Maria Nikolaou, et al.
Journal of Cardiovascular Pharmacology|July 9, 2020
Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical UseZoltán Papp, Piergiuseppe Agostoni, Julian Alvarez, et al.
Pageof 24